Zydus Lifesciences subsidiary Zydus Worldwide DMCC has received final approval from the United States Food and Drug Administration (USFDA) to market Efinaconazole Topical Solution, 10%. (US RLD: Jublia?). Efinaconazole is an azole antifungal used for the topical treatment of Onychomycosis of the toenails due to Trichophyton rubrum and Trichophyton mentagrophytes. The drug will be manufactured at the groups topical manufacturing facility at, Ahmedabad, India. Jublia? […]
Sales rise 45.49% to Rs 337.41 crore
Total Operating Income rise 11.40% to Rs 3457.48 crore
Sales rise 6.11% to Rs 589.89 crore
The frontline indices ended near the days high with robust gains on Monday, tracking positive global cues. The Nifty ended above the 16,250 level. IT, PSU banks and metals stocks advanced while pharma, FMCG and healthcare shares declined. As per provisional closing data, the barometer index, the S&P BSE Sensex, was up 760.37 points or 1.41% to 54,521.15. The Nifty 50 index added 229.30 points […]
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
